Concepta PLC Change of Adviser (6811T)
22 Luglio 2020 - 8:00AM
UK Regulatory
TIDMCPT
RNS Number : 6811T
Concepta PLC
22 July 2020
Concepta PLC
("Concepta" or the "Company")
Change of Adviser
Concepta PLC (AIM: CPT), the personalised healthcare company,
announces the appointment of Oberon Capital, part of the Oberon
Investments Ltd group, as joint broker with immediate effect.
Concepta plc www.conceptaplc.com
P enny McCormick , Chief Executive via Walbrook PR
Officer
Maddy Kennedy, Chief Financial
Officer
SPARK Advisory Partners Limited Tel: +44 (0)20 3368 3550
(NOMAD)
Neil Baldwin
Novum Securities (Joint Broker) Tel: +44 (0)20 7399 9400
Colin Rowbury
Oberon Capital Ltd (Joint Broker) Tel: +44 (0)203 179 5344
Mike Seabrook mikeseabrook@oberoninvestments.com
Walbrook PR Ltd (Media & Investor Tel: +44 (0)20 7933 8780 or concepta@walbrookpr.com
Relations)
Paul McManus Mob: +44(0)7980 541 893
About Concepta PLC ( www.conceptaplc.com )
Concepta PLC is an AIM-quoted pioneering UK healthcare company
that has developed a proprietary product MYLO, targeted at the
personalized mobile health market with a primary focus on hormone
testing and increasing a woman's chances of naturally getting
pregnant and to provide insight to unexplained infertility.
MYLO is currently the only consumer product which allows both
quantitative and qualitative home (self-test) test measurement of a
woman's personal luteinizing hormone (LH) during ovulation and
human chorionic gonadotropin (hCG) hormone level during pregnancy,
facilitating higher conception rates and early diagnosis of
fertility issues. The proposition of MYLO is to empower women to
better understand their hormone levels and menstrual cycle and help
women conceive naturally by identifying their window of fertility
and optimal time for conception.
The Company has received CE-mark certification for MYLO and has
launched its first product in the UK. The Company is preparing
plans to roll-out across the core EU countries in 2020 and
2021.
MYLO is expected to be beneficial to users who have been unable
to conceive after 6 months of trying. This highly motivated target
group of women won't typically be offered medical intervention
until after 12 months of unsuccessfully trying to conceive, with
IVF not usually offered until after two years of trying to
conceive. Research indicates couples start to take positive action
ahead of this time typically with little medical support to help
them do so.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
APPEAKXFALXEEFA
(END) Dow Jones Newswires
July 22, 2020 02:00 ET (06:00 GMT)
Grafico Azioni Myhealthchecked (LSE:MHC)
Storico
Da Mar 2024 a Apr 2024
Grafico Azioni Myhealthchecked (LSE:MHC)
Storico
Da Apr 2023 a Apr 2024